Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Prana Biotechnology Ltd (ATHE : NSDQ)
 
 • Company Description   
Prana Biotechnology was established to commercialize research into Alzheimer's disease and other major age-related degenerative disorders. Their mission is to develop diagnostic and therapeutic drugs to treat the central disease pathways that cause degeneration of the brain as the aging process progresses. Prana's technology has emerged from its researchers at prominent international institutions such as Massachusetts General Hospital at Harvard Medical School and the University of Melbourne.

Number of Employees: 11

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.66 Daily Weekly Monthly
20 Day Moving Average: 140,088 shares
Shares Outstanding: 22.60 (millions)
Market Capitalization: $14.98 (millions)
Beta: 1.32
52 Week High: $2.75
52 Week Low: $0.58
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -15.05% -7.27%
12 Week -22.00% -15.70%
Year To Date -7.97% 9.00%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
LEVEL 3 460 BOURKE STREET
-
MELBOURNE,C3 VIC 3000
AUS
ph: 61-3-9349-4906
fax: 61-3-9348-0377
we-aualterity@we-worldwide.com http://alteritytherapeutics.com
 
 • General Corporate Information   
Officers
David A. Stamler - Chief Executive Officer
Geoffrey P. Kempler - Chairman
Kathryn J.E. Andrews - Chief Financial Officer
Lawrence B. Gozlan - Director
Peter A. Marks - Director

Peer Information
Prana Biotechnology Ltd (CORR.)
Prana Biotechnology Ltd (RSPI)
Prana Biotechnology Ltd (CGXP)
Prana Biotechnology Ltd (BGEN)
Prana Biotechnology Ltd (GTBP)
Prana Biotechnology Ltd (RGRX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 02155X106
SIC: 2834
Fiscal Year
Fiscal Year End: June
Last Reported Quarter: -
Next Expected EPS Date: -
Share - Related Items
Shares Outstanding: 22.60
Most Recent Split Date: 3.00 (0.17:1)
Beta: 1.32
Market Capitalization: $14.98 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: -  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 0.50
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
03/31/22 - -
12/31/21 - -
09/30/21 - -
ROA
03/31/22 - -
12/31/21 - -
09/30/21 - -
Current Ratio
03/31/22 - -
12/31/21 - 11.92
09/30/21 - -
Quick Ratio
03/31/22 - -
12/31/21 - -
09/30/21 - -
Operating Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Net Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Pre-Tax Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Book Value
03/31/22 - -
12/31/21 - 1.33
09/30/21 - -
Inventory Turnover
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Equity
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Capital
03/31/22 - -
12/31/21 - -
09/30/21 - -
 

Powered by Zacks Investment Research ©